Involvement of the pituitary-specific transcription factor Pit-1 in somatolactotrope cell growth and death: An approach using dominant-negative Pit-1 mutants

Molecular Endocrinology

Volumn 20, Issue 12, 2006, Pages 3212-3227

  Pellegrini, Isabelle ^a,c   Roche, Cathy ^a   Quentien, Marie Helene ^a   Ferrand, Mireille ^a   Gunz, Ginette ^a   Thirion, Sylvie ^a   Bagnis, Claude ^b   Enjalbert, Alain ^a   Franc, Jean Louis ^a  

^a CNRS   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; TRANSCRIPTION FACTOR PIT 1;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DELETION MUTANT; DNA BINDING; DRUG INHIBITION; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HORMONE DEFICIENCY; HORMONE RELEASE; LENTIVIRUS VECTOR; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TRANSCRIPTION INITIATION;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; DWARFISM, PITUITARY; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; LENTIVIRUS; MUTATION; PITUITARY HORMONES; TRANSCRIPTION FACTOR PIT-1; TRANSFECTION;

EID: 33751513966     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2006-0122     Document Type: Article

References (43)

1. Scully KM, Rosenfeld MG 2002 Pituitary development: regulatory codes in mammalian organogenesis. Science 295:2231-2235
2. Andersen B, Rosenfeld MG 1994 Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269:29335-29338
3. Li S, Crenshaw 3rd EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-553
4. Castrillo JL, Theill LE, Karin M 1991 Function of the homeodomain protein GHF1 in pituitary cell proliferation. Science 253:197-199
5. Pellegrini I, Barlier A, Gunz G, Figarella-Branger D, Enjalbert A, Grisoli F, Jaquet P 1994 Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 79:189-196
6. Andersen B, Rosenfeld MG 2001 POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev 22:2-35
7. Reynaud R, Saveanu A, Barlier A, Enjalbert A, Brue T 2004 Pituitary hormone deficiencies due to transcription factor gene alterations. Growth Horm IGF Res 14:442-448
8. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE 1992 A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115-1118
9. Vallette-Kasic S, Pellegrini-Bouiller I, Sampieri F, Gunz G, Diaz A, Radovick S, Enjalbert A, Brue T 2001 Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates. Mol Endocrinol 15:411-420
10. Naldini L, Blomer U, Gage FH, Trono D, Verma IM 1996 Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382-11388
11. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D 1996 In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267
12. Trouillas J, Girod C, Claustrat B, Joly-Pharaboz MO, Chevallier P 1990 Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma. Cancer Res 50:4081-4086
13. Windle JJ, Weiner RI, Mellon PL 1990 Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 4:597-603
14. Henry-Mowatt J, Dive C, Martinou JC, James D 2004 Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 23:2850-2860
15. Danial NN, Korsmeyer SJ 2004 Cell death: critical control points. Cell 116:205-219
16. Wang ZB, Liu YQ, Cui YF 2005 Pathways to caspase activation. Cell Biol Int 29:489-496
17. Fombonne J, Reix S, Rasolonjanahary R, Danty E, Thirion S, Laforge-Anglade G, Bosler O, Mehlen P, Enjalbert A, Krantic S 2004 Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype. Mol Biol Cell 15:4938-4948
18. Torriglia A, Perani P, Brossas JY, Altairac S, Zeggai S, Martin E, Treton J, Courtois Y, Counis MF 2000 A caspase-independent cell clearance program. The LEI/L-DNase II pathway. Ann NY Acad Sci 926:192-203
19. Savage JJ, Yaden BC, Kiratipranon P, Rhodes SJ 2003 Transcriptional control during mammalian anterior pituitary development. Gene 319:1-19
20. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG 2000 Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290:1127-1131
21. Ingraham HA, Flynn SE, Voss JW, Albert VR, Kapiloff MS, Wilson L, Rosenfeld MG 1990 The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61:1021-1033
22. Kishimoto M, Okimura Y, Yagita K, Iguchi G, Fumoto M, Iida K, Kaji H, Okamura H, Chihara K. 2002 Novel function of the transactivation domain of a pituitary-specific transcription factor, Pit-1. J Biol Chem 277:45141-45148
23. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, Kohno H 1992 Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1:56-58
24. Cohen RN, Brue T, Naik K, Houlihan CA, Wondisford FE, Radovick S 2006 The Role of CBP/p300 Interactions and Pit-1 Dimerization in the Pathophysiological Mechanism of Combined Pituitary Hormone Deficiency. J Clin Endocrinol Metab 91:239-247
25. Jacobson EM, Li P, Leon-del-Rio A, Rosenfeld MG, Aggarwal AK 1997 Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev 11:198-212
26. Kishimoto M, Okimura Y, Fumoto M, Iguchi G, Iida K, Kaji H, Chihara K 2003 The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes. Eur J Endocrinol 148:619-625
27. Glass CK, Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141
28. Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG 1995 Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev 9:1992-2006
29. Enwright 3rd JF, Kawecki-Crook MA, Voss TC, Schaufele F, Day RN 2003 A PIT-1 homeodomain mutant blocks the intranuclear recruitment of the CCAAT/enhancer binding protein α required for prolactin gene transcription. Mol Endocrinol 17:209-222
30. Lee EJ, Duan WR, Jakacka M, Gehm BD, Jameson JL 2001 Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142:3756-3763
31. Caporali S, Imai M, Altucci L, Cancemi M, Caristi S, Cicatiello L, Matarese F, Penta R, Sarkar DK, Bresciani F, Weisz A 2003 Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. Mol Biol Cell 14:5051-5059
32. Li X, Perissi V, Liu F, Rose DW, Rosenfeld MG 2002 Tissue-specific regulation of retinal and pituitary precursor cell proliferation. Science 297:1180-1183
33. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, Brault V, Ruiz-Lozano P, Nguyen HD, Kemler R, Glass CK, Wynshaw-Boris A, Rosenfeld MG 2002 Identification of a Wnt/Dvl/beta-Catenin -> Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111:673-685
34. Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris A, Rose DW, Rosenfeld MG 2003 Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 100:3245-3250
35. Jiang X, Wang X 2004 Cytochrome C-mediated apoptosis. Annu Rev Biochem 73:87-106
36. Kroemer G, Martin SJ 2005 Caspase-independent cell death. Nat Med 11:725-730
37. Lin C, Lin SC, Chang CP, Rosenfeld MG 1992 Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360:765-768
38. Gaiddon C, de Tapia M, Loeffler JP 1999 The tissue-specific transcription factor Pit-1/GHF-1 binds to the c-fos serum response element and activates c-fos transcription. Mol Endocrinol 13:742-751
39. Quentien MH, Pitoia F, Gunz G, Guillet MP, Enjalbert A, Pellegrini I 2002 Regulation of prolactin, GH, and Pit-1 gene expression in anterior pituitary by Pitx2: An approach using Pitx2 mutants. Endocrinology 143:2839-2851
40. Rouas R, Uch R, Cleuter Y, Jordier F, Bagnis C, Mannoni P, Lewalle P, Martiat P, Van den Broeke A 2002 Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 9:715-724
41. Delhase M, Vergani P, Malur A, Velkeniers B, Teugels E, Trouillas J, Hooghe-Peters EL 1993 Pit-1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours. J Mol Endocrinol 11:129-139
42. Waterhouse NJ, Trapani JA 2003 A new quantitative assay for cytochrome c release in apoptotic cells. Cell Death Differ 10:853-855
43. Ekert PG, Read SH, Silke J, Marsden VS, Kaufmann H, Hawkins CJ, Gerl R, Kumar S, Vaux DL 2004 Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 165:835-842